DermAid

DermAid

hydrocortisone

Manufacturer:

Ego

Distributor:

Zuellig Pharma
Full Prescribing Info
Contents
Hydrocortisone.
Description
DermAid contains dissolved hydrocortisone for improved effectiveness in a special occlusive cream base. It is paraben-, lanolin- and chlorocresol-free with a pH 5.
Action
Anti-inflammatory, antipruritic topical corticosteroid.
Indications/Uses
For the symptomatic relief of inflammation associated with steroid responsive conditions such as dermatitis, eczema and psoriasis.
Dosage/Direction for Use
Apply a thin film 1 to 3 times daily or as directed by the physician to affected areas.
Contraindications
Hypersensitivity to hydrocortisone.
Vaccinia, chickenpox, herpes and other viral infections, tuberculosis of the skin and syphilitic skin disorders.
Do not use hydrocortisone cream on the face or near the eyes, on the anal or genital region, or on broken skin.
Special Precautions
For external use only. Avoid contact with eyes. Do not use for acne. Do not use under waterproof bandages.
Avoid large amounts, occlusion and prolonged treatment.
Adjunct Therapy: As soap may irritate the skin, cleanse with a soap alternative eg, Pinetarsol gel or QV wash. As prolonged use is not advisable, use alternatives eg, Egoderm ointment (for soothing effect), or Egoderm cream (for emollient effect if the skin is dry) for continued control if long-term therapy is required. To help prevent recurrence, use QV cream.
Use in Pregnancy & Lactation: Prolonged use should be avoided. Consult a doctor if pregnant or breastfeeding.
Use in Children: Do not use on children under 2 years except under medical supervision.
Infants: Prolonged use should be avoided as adrenal suppression may occur in infants.
Use In Pregnancy & Lactation
Prolonged use should be avoided. Consult a doctor if pregnant or breastfeeding.
Side Effects
After application, a slight stinging sensation may occasionally be noticed. This transient symptom is most likely to disappear after several applications.
Intolerance to the occlusive dressing (miliary eruptions, folliculitis) may be observed, as with other corticosteroids. In such cases, the use of an occlusive dressing should be discontinued. The use of the steroid may also need to be reduced or discontinued, depending on the severity of the reaction.
In long-term treatment of extensive skin areas with occlusive dressing, one should bear in mind the possibility of inhibition of adrenal function. Therefore, adrenal function should be monitored under these circumstances.
'Stretch marks' may appear, especially in skin folds such as the groin or armpits.
Blurred vision.
Storage
Store below 25°C.
MIMS Class
Topical Corticosteroids
ATC Classification
D07AA02 - hydrocortisone ; Belongs to the class of weak (group I) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
DermAid cream 0.5 %
Packing/Price
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in